Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic ...

clipped to a dual polycarbonate ring system that was approved by U.S. Food and Drug Administration in 2003. It acts as a biological bandage with the stromal side in contact with the cornea.

To safely wear colored contact lenses, consult an eye care professional, follow proper hygiene practices, and only purchase FDA-approved lenses from reputable retailers. Colored contact lenses might ...

Obe-cel is the first FDA-approved CAR T-cell therapy for B-ALL without a REMS requirement, based on the FELIX trial's positive outcomes. The FELIX trial reported a 63% complete remission rate ...

It happens when a parasite that can be found in water invades the eye, damaging the cornea, causing severe pain and ...

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

Pfizer’s bivalent RSV prefusion F vaccine has been approved to prevent lower respiratory tract disease resulting from the respiratory syncytial virus in adults 18 to 59 years of age who are at ...

18.2-positive as determined by an FDA-approved test. Vyloy has become the first and only CLDN18.2-targeted therapy approved in the United States. The approval is based on the phase 3 SPOTLIGHT and ...

After a prior rejection, Astellas can head into the weekend celebrating a class-first FDA approval for its new gastric cancer med Vyloy. The FDA on Friday gave Vyloy (zolbetuximab) the thumbs-up ...

The U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD). Vyalev is the first and only ...

Novocure received a long-sought FDA approval for the use of its Tumor Treating Fields technology against metastatic non-small cell lung cancer—which the company described as the first treatment ...